These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4553294)

  • 1. [Boron compounds from the pharmaceutical-chemical viewpoint].
    Kliegel W
    Pharmazie; 1972 Jan; 27(1):1-14. PubMed ID: 4553294
    [No Abstract]   [Full Text] [Related]  

  • 2. [PHB--a new drug of significant antifungal activity in dermatophytosis].
    Altaras I; Lerer N
    Harefuah; 1974 Aug; 87(4):174-5. PubMed ID: 4417409
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of 10B antitumoral compounds by means of flow-injection into ESI-MS/MS.
    Basilico F; Sauerwein W; Pozzi F; Wittig A; Moss R; Mauri PL
    J Mass Spectrom; 2005 Dec; 40(12):1546-9. PubMed ID: 16320299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [External therapy of skin diseases].
    Bettermann J; Gehrels PE; Herger R; Pfister R; Wild OE
    Fortschr Med; 1974 Apr; 92(12):531-6. PubMed ID: 4274667
    [No Abstract]   [Full Text] [Related]  

  • 5. New compounds for neutron capture therapy (NCT) and their significance.
    Fairchild RG; Bond VP
    Strahlentherapie; 1984 Dec; 160(12):764-70. PubMed ID: 6393459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic experience in the use of a new antimycotic gel with phenylhydrargyri boras as an effective substance].
    Pólay A; Szilágyi I
    Mykosen; 1972 Mar; 15(3):111-7. PubMed ID: 4636061
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of quinine and quinidine by the weight of tetraphenylborides. Regeneration of their bases].
    Bonnard J
    J Pharm Belg; 1967; 22(9):354-66. PubMed ID: 5608934
    [No Abstract]   [Full Text] [Related]  

  • 8. [Two new fungicides and insecticides for the protection of entomological collections].
    RAGEAU J; VERVENT G
    Ann Parasitol Hum Comp; 1957; 32(4):460-2. PubMed ID: 13498542
    [No Abstract]   [Full Text] [Related]  

  • 9. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.
    Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN
    Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study of the antifungal effect of phenyl mercury borate. II. Animal study].
    Grigoriu D; Grigoriu A
    Mykosen; 1970 Feb; 13(2):85-90. PubMed ID: 5475241
    [No Abstract]   [Full Text] [Related]  

  • 12. Boron medicinal chemistry and synthetic aspects.
    Ahmet JT; Spencer J
    Future Med Chem; 2013 Apr; 5(6):621-2. PubMed ID: 23617424
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of dermatomycoses with a new hydrogel].
    Winkler A
    Mykosen; 1970 Oct; 13(10):481-9. PubMed ID: 5486008
    [No Abstract]   [Full Text] [Related]  

  • 14. [STUDIES ON ANTI-CANCER AGENTS. XI. SYNTHESIS OF METHANESULFONATES OF VARIOUS CARBINOLS AND PHENOLIC COMPOUNDS AND THEIR PHARMACOLOGICAL ACTIVITY].
    KAMETANI T; UMEZAWA O; SEKINE K; ODA T; ISHIGURO M; MIZUNO D
    Yakugaku Zasshi; 1964 Mar; 84():237-46. PubMed ID: 14185035
    [No Abstract]   [Full Text] [Related]  

  • 15. Zirconocene-mediated highly regio- and stereoselective synthesis of multisubstituted olefins starting from 1-alkynylboronates.
    Nishihara Y; Miyasaka M; Okamoto M; Takahashi H; Inoue E; Tanemura K; Takagi K
    J Am Chem Soc; 2007 Oct; 129(42):12634-5. PubMed ID: 17910456
    [No Abstract]   [Full Text] [Related]  

  • 16. [The metabolic products of microorganisms. Boromycin].
    Hütter R; Keller-Schierlein W; Knüsel F; Prelog V; Rodgers GC; Suter P; Vogel G; Voser W; Zähner H
    Helv Chim Acta; 1967; 50(6):1533-9. PubMed ID: 6081908
    [No Abstract]   [Full Text] [Related]  

  • 17. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron reagents in process chemistry: Excellent tools for selective reductions.
    Burkhardt ER; Matos K
    Chem Rev; 2006 Jul; 106(7):2617-50. PubMed ID: 16836295
    [No Abstract]   [Full Text] [Related]  

  • 20. A method to build an analytic model of the 10B(n,alpha)7Li reaction rate space distribution for boron neutron capture therapy (BNCT).
    Morand J; Moss R; Hachem S; Sauerwein W
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S149-52. PubMed ID: 19375922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.